Workflow
Why BDC Dividend Cuts Aren't The Red Flag Investors Think
Seeking Alpha· 2026-02-09 22:05
To celebrate High Yield Investor turning five, we’re offering a 30-day money-back guarantee . Now is the perfect time to join. We have just released our Top Picks for 2026 , and with the guarantee, you have everything to gain and nothing to lose.Private credit stocks have fallen sharply recently, as evidenced by weakness in publicly traded business development companies (BDCs) ( BIZD ), as well as in alternative asset managers that have heavy concentration in private credit. ForSamuel Smith has a diverse ba ...
Diversified Royalty Corp. Announces the Exercise of the Over-Allotment Option in Connection with its Recently Completed $60 Million Bought Deal Offering of 5.75% Convertible Unsecured Subordinated Debentures
Globenewswire· 2026-02-09 22:05
VANCOUVER, British Columbia, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Diversified Royalty Corp. (TSX: DIV, DIV.DB.A and DIV.DB.B) (the “Corporation” or “DIV”) is pleased to announce that the underwriters, in respect of its recently completed bought deal public offering (the “Offering”) of $60,000,000 aggregate principal amount of 5.75% convertible unsecured subordinated debentures (the “Debentures”) at a price of $1,000 per Debenture (the “Offering Price”), have fully exercised their previously announced option to ...
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, February 25, 2026
Businesswire· 2026-02-09 22:05
About Maravai Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. Maravai's companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologics safety testing to many of the world's leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapy companies. SAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences, Inc. (Marava ...
Melius Downgrades Microsoft to Hold Citing AI Capex Pressures and Valuation Concerns
Financial Modeling Prep· 2026-02-09 22:04
Group 1 - Melius downgraded Microsoft from Buy to Hold due to increasing competitive threats from AI and rising capital expenditure requirements [1] - Microsoft's 365 business is under pressure from AI-driven competitors, requiring higher capital spending to compete with firms like Alphabet and Amazon [2] - Higher investment levels could negatively impact free cash flow, while insufficient spending may indicate execution challenges or earnings management [2] Group 2 - Concerns were raised about long-term assumptions regarding OpenAI, with doubts about its ability to generate free cash flow compared to competitors like Anthropic and Google [3] - Melius suggested that public investors might push OpenAI towards a less capital-intensive model in the future [3] - Microsoft is currently trading at approximately 49 times FY27 enterprise value to free cash flow, indicating it may be overvalued based on revised estimates [4] Group 3 - Melius lowered its price target for Microsoft to $430 and set Oracle's target at $160, while reiterating a Sell rating on Adobe [4]
3 AI Infrastructure Stocks That Can Outperform Nvidia Over The Next 5 Years
247Wallst· 2026-02-09 22:04
It's hard to have any conversation about the stock market without touching on artificial intelligence. ...
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Ultragenyx Pharmaceutical Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RARE
TMX Newsfile· 2026-02-09 22:04
New York, New York--(Newsfile Corp. - February 9, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) between August 3, 2023 and December 26, 2025. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 6, 2026. SO WHAT: If you purchased Ultragenyx common stock during the Class Period you may be enti ...
NatWest Group plc (NWG) M&A Call Transcript
Seeking Alpha· 2026-02-09 22:04
PresentationPaul ThwaiteGroup CEO & Executive Director Good morning, everyone, and thank you for joining us at short notice following our announcement of the acquisition of Evelyn Partners. I'm here with Katie. I'll start with a short introduction before we take your questions. With the GBP 2.7 billion acquisition of Evelyn Partners, we are creating the U.K.'s leading private banking and wealth manager. This accelerates delivery of the group strategy by increasing our exposure to a highly attractive growin ...
TMX Group Limited (OTC:TMXXF) Maintains "Outperform" Rating
Financial Modeling Prep· 2026-02-09 22:03
Core Insights - TMX Group Limited, trading as TMXXF, is a significant entity in the financial services sector, operating various exchanges including the Toronto Stock Exchange and providing trading, clearing, and data solutions [1] - RBC Capital has maintained an "Outperform" rating for TMXXF, indicating expectations for the stock to perform better than the overall market, with the current stock price at $33.99, reflecting a 2.01% increase [2][6] - The recent Q4 2025 earnings call provided insights into TMX Group's financial performance, helping investors assess the company's health and strategic direction [3] Financial Performance - TMXXF's stock price has seen fluctuations over the past year, with a high of $42.19 and a low of $32.93, currently priced at $33.99, which is closer to its yearly low, suggesting potential for growth [4] - The market capitalization of TMXXF is approximately $9.46 billion, indicating a strong presence in the market [4][6] - The trading volume for TMXXF is low, with only 100 shares traded today, which may indicate limited liquidity affecting price stability [5][6]
The Devon-Coterra Merger: 7 Key Questions Answered
Investor Place· 2026-02-09 22:03
Devon Energy Corp. (NYSE: DVN) announced an all-stock merger with Coterra Energy Inc. (NYSE: CTRA) on February 2, creating a $58 billion energy giant. The deal has sparked plenty of investor questions about what it means for DVN stock and its dividend.Here are the seven most important questions investors are asking — and the answers you need.1. What Happens to the Devon Energy Dividend After the Merger?This is the top question on every income investor’s mind.Once the merger closes in the second quarter of 2 ...
Under Armour Shares Rise After Williams Trading Lifts Price Target
Financial Modeling Prep· 2026-02-09 22:03
Core Viewpoint - Under Armour's stock price increased nearly 3% after Williams Trading raised its price target to $10 from $8 while maintaining a Buy rating [1] Group 1: Marketing Strategy - Williams Trading expressed confidence in Under Armour's evolving marketing strategy, which is expected to strengthen brand loyalty and resonate with consumers [2] - The new "click-clack" advertising campaign supporting U.S. Women's Flag Football is anticipated to build brand affinity among younger female consumers [2] Group 2: Localized Marketing Efforts - Under Armour is enhancing localized marketing by showcasing its support for high school football teams, with 3,000 teams outfitted by the brand [3] - The flagship store in Baltimore prominently displays local high school football helmets, reinforcing community connections [3] Group 3: Brand Appeal and Product Offerings - Under Armour's brand appeal is reportedly broader in local markets like Baltimore compared to the national level [4] - The firm believes that supporting high school athletes nationwide will extend brand affinity and drive demand for new lifestyle footwear, including the Sola sneaker priced at $120 and the HB-Lo sneaker priced at $100 [4]